Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for (lung OR pulmonary) AND surgery

Edit search filters
  1. Durvalumab+/- Tremelimumab In Combination With Platinum Based Chemotherapy In Untreated Extensive-Stage Small Cell Lung Cancer (Caspian)

    Scottsdale/Phoenix, AZ

  2. A Study of the Safety and Effectiveness of INC280 Alone and in Combination with Erlotinib, When Compared to Chemotherapy in Advanced or Metastatic Non-Small Cell Lung Cancer Patients with EGFR Mutation and Amplified cMET

    Rochester, MN

  3. Extension Trial On Efficacy /​ Safety Of L-CsA + SoC In Treating BOS In Post Single Or Double Lung Transplant (BOSTON-3) (BOSTON-3)

    Jacksonville, FL

  4. Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

    Rochester, MN

  5. PKCι & MTOR Inhibition With Auranofin+Sirolimus For Squamous Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. Study Of Zanzalintinib In Combination With Immuno-Oncology Agents In Participants With Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer